Also, the ZEB2 expression level is increased in CD133+ cancer stem-like cells of ovarian cancer cells, and its silencing is associated with downregulated MMP-9 expression and decreased migration (Li et al., 2021[65]). This evidence concerns the gene ZEB2 and ovarian carcinoma.